ANEB - שווי פירמה כולל Anebulo Pharma

This chart illustrates that the market value of Anebulo Pharmaceuticals (ANEB) is 5.64. Anebulo Pharmaceuticals is gradually deploying its existing capital toward research while currently generating no revenue. The company is outsourcing the testing process for overdose medications to third-party contractors to protect its patents. Business success depends on the results of medical trials, the expansion of cannabis legalization, and the implementation of new therapeutic standards in emergency medicine.

This metric is sensitive to changes in debt load and liquidity levels within the financial statements of Anebulo Pharmaceuticals (ANEB). It determines the total cost of business acquisition by combining the market value of shares with net debt. For this developer of cannabinoid antidotes, this indicator reflects the investment attractiveness of the narrow emergency medicine niche. The company's valuation allows for a comparison between market capitalization and the potential for product implementation in hospitals. This enterprise value trend visualizes the actual acquisition price of the asset.